Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 15, 2025

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …

Disrupt-X and Tecpro Solutions Partner to Deliver Corporate Real Estate Platform Across the UAE and Middle East
DUBAI, DUBAI, UNITED ARAB EMIRATES, May 15, 2025 /EINPresswire.com/ -- Disrupt-X, a leading provider of enterprise technology solutions for corporate real estate, has partnered with Tecpro Solutions to expand the reselling of the ALEF 360° platform …

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN DIEGO, …

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …

STR Talk Officially Launches: The Next-Gen Encrypted Messaging App for the Web3 Era
STR Talk empowers users to connect through encrypted conversations built on blockchain validation, eliminating third-party interference. DELAWARE, DE, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- SourceLess, the pioneering Web3 infrastructure …

Colle AI Expands User Experience With Flexible NFT Deployment Tools
New platform tools offer more control over minting, asset routing, and smart contract settings across supported blockchains LONDON, LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- Colle AI (COLLE), the multichain AI-driven NFT platform, has …

Lancaster Granted Exploration License at Lake Cargelligo Gold Project
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce that the vendor of the Lake Cargelligo Gold Project received final approval from the State of New …

كيتا تكشف توجهات توصيل الطعام في السعودية للربع الأول من 2025
RIYADH, RIYADH PROVINCE, SAUDI ARABIA, May 15, 2025 /EINPresswire.com/ -- أعلنت "كيتا"، الذراع الدولية لشركة "ميتوان" الصينية العملاقة في خدمات التوصيل حسب الطلب، عن تقريرها للربع الأول من عام 2025، كاشفة عن توجهات طلبات السعوديين، وما يطلبونه، وأين …

Keeta reveals Saudi’s Food Delivery Trends in Q1 2025
RIYADH, RIYADH PROVINCE, SAUDI ARABIA, May 15, 2025 /EINPresswire.com/ -- Keeta, the international subsidiary of Meituan, China’s on-demand delivery giant, has released Q1 2025 insights, revealing what the Saudi population ordered, where food trends are …

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
Biofrontera has received patent approval for the revised formulation of Ameluz®, which extends patent protection through to December 2043 Ameluz PDT offers the potential for effective treatment of moderate to severe acne without the side effects associated …

Esports World Cup Foundation Welcomes OBSBOT as Official Camera and Webcam Partner for Esports World Cup 2025
Riyadh, Saudi Arabia, May 15, 2025 (GLOBE NEWSWIRE) -- The Esports World Cup Foundation (EWCF) today announced OBSBOT, as an official camera and webcam partner for the Esports World Cup (EWC) 2025, set to return to Riyadh, Saudi Arabia, this summer. The …

Dr. Jose Arnold Tariga from the USA Selected as Finalist for Aster Guardians Global Nursing Award 2025 Worth USD 250,000
Boston/Dubai, May 15, 2025 (GLOBE NEWSWIRE) -- Dr. Jose Arnold Tariga, a Filipino-American nurse leader and educator from Boston, USA, selected among top 10 finalists from over 100,000 global entries across 199 countries Winner to be announced at a grand …

EVA AI Launches First Real-Time AI Antivirus for Web3 to Block On-Chain Threats
DUBAI, United Arab Emirates, May 15, 2025 (GLOBE NEWSWIRE) -- EVA AI - a leading provider of decentralized security solutions and one of Q1’s top-performing on-chain projects - has launched EVA Sentinel Extension, the first AI-powered antivirus built …

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
In a release issued under the same headline earlier today by Mersana Therapeutics, Inc. (NASDAQ: MRSN), please note that there was a transcription error in the last cell of the first table. The Median OS should have been 5.7 months rather than 1.7 months. …

Silo Pharma Announces Pricing of $2 Million Public Offering
SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the pricing of a public …

Wix Aims to Disrupt the Design Experience with Wixel, The Next-Generation AI-Powered Visual Design Platform for Anyone
Wix is redefining creative empowerment with the launch of Wixel – a standalone AI-powered design platform that brings the most advanced visual design capabilities into a single intuitive interface NEW YORK – Wix.com Ltd. (NASDAQ: WIX), the leading SaaS …

High Grade at Globex’s Carp Fluorspar Property, Nevada
ROUYN-NORANDA, Quebec, May 15, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …